Anti-Nuclear Matrix Protein p84 antibody [3121C2a] (ab54370)
Key features and details
- Mouse monoclonal [3121C2a] to Nuclear Matrix Protein p84
- Suitable for: WB
- Reacts with: Recombinant fragment
- Isotype: IgG2b
Overview
-
Product name
Anti-Nuclear Matrix Protein p84 antibody [3121C2a]
See all Nuclear Matrix Protein p84 primary antibodies -
Description
Mouse monoclonal [3121C2a] to Nuclear Matrix Protein p84 -
Host species
Mouse -
Tested applications
Suitable for: WBmore details -
Species reactivity
Reacts with: Recombinant fragment -
Immunogen
Recombinant fragment: QYLKGQVKFK SSNYVLTDEQ SLWIEDTTKS VYQLLSENPP DGERFSKMVE HILNTEENWN SWKNEGCPSF VKERTSDTKP TRIIRKRTAP EDFLGKGPTK , corresponding to internal sequence amino acids 330-437 of Human Nuclear Matrix Protein p84
-
General notes
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. -
Storage buffer
pH: 7.40
Preservative: 0.05% Sodium azide
Constituents: 0.03% Potassium phosphate, 0.812% Sodium chloride, 0.1312% Sodium phosphate, 0.0225% Potassium chloride, 1% BSA, PBS -
Concentration information loading...
-
Purity
Protein G purified -
Purification notes
ab54370 was purified using protein G column chromatography from culture supernatant of hybridoma cultured in a medium containing bovine IgG-depleted (approximately 95%) fetal bovine serum and filtered through a 0.22µm membrane. -
Clonality
Monoclonal -
Clone number
3121C2a -
Isotype
IgG2b -
Research areas
Associated products
-
Compatible Secondaries
-
Isotype control
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab54370 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
WB |
Use at an assay dependent concentration. Predicted molecular weight: 76 kDa.
|
Notes |
---|
WB
Use at an assay dependent concentration. Predicted molecular weight: 76 kDa. |
Target
-
Function
Component of the THO subcomplex of the TREX complex. The TREX complex specifically associates with spliced mRNA and not with unspliced pre-mRNA. It is recruited to spliced mRNAs by a transcription-independent mechanism. Binds to mRNA upstream of the exon-junction complex (EJC) and is recruited in a splicing- and cap-dependent manner to a region near the 5' end of the mRNA where it functions in mRNA export. The recruitment occurs via an interaction between THOC4 and the cap-binding protein NCBP1. DDX39B functions as a bridge between THOC4 and the THO complex. The TREX complex is essential for the export of Kaposi's sarcoma-associated herpesvirus (KSHV) intronless mRNAs and infectious virus production. The recruitment of the TREX complex to the intronless viral mRNA occurs via an interaction between KSHV ORF57 protein and THOC4.
Regulates transcriptional elongation of a subset of genes. Participates in an apoptotic pathway which is characterized by activation of caspase-6, increases in the expression of BAK1 and BCL2L1 and activation of NF-kappa-B. This pathway does not require p53/TP53, nor does the presence of p53/TP53 affect the efficiency of cell killing. Activates a G2/M cell cycle checkpoint prior to the onset of apoptosis. Apoptosis is inhibited by association with RB1. -
Tissue specificity
Ubiquitous. Expressed in various cancer cell lines. Expressed at very low levels in normal breast epithelial cells and highly expressed in breast tumors. Expression is strongly associated with an aggressive phenotype of breast tumors and expression correlates with tumor size and the metastatic state of the tumor progression. -
Sequence similarities
Contains 1 death domain. -
Domain
An intact death domain is needed for apoptosis. -
Post-translational
modificationsExpression is altered specifically during apoptosis and is accompanied by the appearance of novel forms with smaller apparent molecular mass. -
Cellular localization
Cytoplasm and Nucleus speckle. Nucleus > nucleoplasm. Nucleus matrix. Cytoplasm. Can shuttle between the nucleus and cytoplasm. Nuclear localization is required for induction of apoptotic cell death. Translocates to the cytoplasm during the early phase of apoptosis execution. - Information by UniProt
-
Form
Nuclear (Isoform 1) and Cytoplasmic (Isoform 1 and 2). -
Alternative names
- hTREX84 antibody
- Death domain containing protein p84N5 antibody
- HPR 1 antibody
see all
Images
-
Anti-Nuclear Matrix Protein p84 antibody [3121C2a] (ab54370) + immunising recombinant fragment
Predicted band size: 76 kDa
Observed band size: 34 kDa why is the actual band size different from the predicted?
The molecular weight of the band on the western blot does not correspond to the molecular weight of the natural protein because only a fragment of the protein was used.
Datasheets and documents
-
Datasheet download
References (0)
ab54370 has not yet been referenced specifically in any publications.